April 12, 2018 / 8:03 PM / 15 days ago

BRIEF-Rigel Makes Statement Regarding Website Error

April 12 (Reuters) - Rigel Pharmaceuticals Inc:

* RIGEL MAKES STATEMENT REGARDING WEBSITE ERROR

* FDA IS CONTINUING ITS REVIEW OF NDA AND PDUFA ACTION DATE FOR FOSTAMATINIB NDA IS APRIL 17

* DUE TO AN ERROR, INACCURATE INFORMATION WAS DISPLAYED REGARDING U.S. FDA’S REVIEW OF NDA FOR FOSTAMATINIB

* CO’S WEBSITE HAS BEEN CORRECTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below